SynthesisDrug design, development and therapy2015

The efficacy and safety of pemetrexed-based doublet therapy compared to pemetrexed alone for the second-line treatment of advanced non-small-cell lung cancer: an updated meta-analysis.

Anyuan Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.